Introduction
Gliomas, comprising astrocytomas and oligodendrogliomas, are the most common primary tumors of the central nervous system (Kleihues and Cavenee, 1997) .
The tumors are believed to originate from a glial progenitor cell or an astrocyte based on the expression of various glial-specific mRNAs and proteins in the tumors. Gliomas are diagnosed based on malignancy into four grades (I-IV). Owing to infiltrative growth and a strong tendency of malignant progression of tumor cells, the prognosis is poor even when diagnosed with a low-grade tumor. The oligodendrogliomas are divided into grade II oligodendroglioma and grade III anaplastic oligodendroglioma. They commonly display overexpression of the epidermal growth factor receptor (EGFR) (Reifenberger et al., 1996) and of ligands and receptors of the platelet-derived growth factor (PDGF) family (Di Rocco et al., 1998) . In high-grade oligodendrogliomas, the malignant progression is often associated with homozygous deletion of the INK4a-ARF locus (Cairncross et al., 1998; Bigner et al., 1999) , which is one of the most frequent mutations found in human glioma (Jen et al., 1994; Schmidt et al., 1994) . INK4a-ARF encodes the tumor suppressor proteins p16 INK4A and p14 ARF (p19 Arf in mouse), which regulates the RB and P53 pathways, respectively. Their separate roles in suppression of spontaneous tumor development in vivo have been studied in mice with targeted deletions of the corresponding genes (Serrano et al., 1996; Kamijo et al., 1997a; Sharpless et al., 2001 Sharpless et al., , 2004 . Arf-null mice showed a high frequency of spontaneous tumors in diverse tissue types, whereas Ink4a-null mice demonstrated a low frequency of spontaneous tumors with a more restricted tissue distribution. The combined loss of Ink4a-Arf displayed a phenotype similar to that of Arf-null mice.
The somatic cell gene transfer model replicationcompetent avian leukemia virus splice acceptor/avian leukemia virus receptor (RCAS/tv-a) has been used to study oncogenic mechanisms of tumor genes during gliomagenesis. Infection with RCAS retroviruses carrying specific genetic mutations can be directed to specific brain cell populations using transgenic mice expressing tv-a from cell type-specific promoters. In Ntv-a mice, the nestin promoter that supports transfer to neural/glial progenitor cells controls expression of tv-a. In Gtv-a, mice tv-a is expressed by the glial fibrillary acidic protein (GFAP) promoter that is active primarily in astrocytes in the newborn mouse brain. In the Ntv-a mice, we have previously shown that various types of gliomas (astrocytomas and oligodendrogliomas) can be induced in wild-type mice by infecting with KRas þ Akt or PDGFB retrovirus (Dai et al., 2001; Uhrbom et al., 2002) . When these oncogenic stimuli were combined with the loss of Ink4a-Arf tumor incidence, latency and malignancy were increased (Dai et al., 2001; Uhrbom et al., 2002) . Furthermore, for KRas-induced astrocytomas, we have shown that there were functionally independent roles of loss of either Ink4a or Arf (Uhrbom et al., 2005) .
In the present study, we have investigated the individual contributions of loss of p16
Ink4a and p19
Arf in PDGFB-induced oligodendroglioma development. We found that the main consequence of Ink4a-loss was to render astrocytes susceptible to PDGFB-induced oncogenesis and that the primary result of Arf-loss was increased tumor malignancy. Results from in vitro studies on primary brain cell cultures supported these findings and suggested a mechanism by which tumor initiation was caused by activation of the mitogen-activated protein kinase (MAPK) pathway via extracellular signal-regulated kinase (Erk), and tumor progression occurred upon loss of p19 Arf resulting in increased levels of cyclin D1 and activation of the phosphoinositide 3-kinase (PI3K) pathway via p70 ribosomal S6 kinase (p70S6K).
Results
To dissect the effect of loss of each of the Ink4a-Arf gene products in vivo, Ntv-a and Gtv-a wild-type mice and mice lacking p16
Ink4a
, p19
Arf or both were injected with RCAS-PDGFB-EGFP (Table 1) . As previously described (Dai et al., 2001) , the PDGFB-induced tumors displayed a histopathology similar to human oligodendroglioma (grade II) (Figure 1a and b) or anaplastic oligodendroglioma (grade III) (Figure 1c and d) . The tumors consisted of small tumor cells with regular, round nuclei and some tumors displayed the 'perinuclear halo' feature where the cytoplasm was cleared from the tumor cell nuclei (Figure 1a and c). They grew diffusely into the normal brain parenchyma and displayed occurrence of the 'secondary structures of Scherer' including tumor cells lining up in the white matter tract of the corpus callosum (Figure 1b) , perivascular satellitosis, perineuronal satellitosis and subpial infiltration (Scherer, 1938) . To be classified as an anaplastic oligodendroglioma, the addition of two or more of the following features had to be present: high tumor cell density with mitotic figures (Figure 1c ), cellular and nuclear pleomorphism, microvascular proliferation and pseudopalisading necrosis (Figure 1d ). Grade III tumors normally displayed grade II tumor histology in some parts of the tumor. Grade II tumors were mostly found in asymptomous 12-week-old animals whereas grade III tumors usually presented earlier than 12 weeks. Some tumors in Gtv-a mice had the histopathology of mixed oligo-astrocytomas. All tumors were positive for the oligodendroglial cell marker NG2 (Figure 1e ) and the neural stem cell marker Sox2 (Figure 1f ). In addition, most tumors showed areas positive for Gfap (Figure 1g ) and nestin ( Figure 1h) .
In Ntv-a mice, significant increase in tumor incidence was found upon loss of either Ink4a (Fischer's exact test, P ¼ 0.0496 (*)) or Ink4a-Arf (Fischer's exact test, P ¼ 0.0159 (*)) compared to wild-type mice (Table 1) . In Gtv-a mice, the separate loss of Ink4a or Arf had a more striking effect (Table 1 ). There was a significant and similar increase in tumor incidence in Ink4aÀ/À and ArfÀ/À mice compared to wild-type mice (Fischer's exact test, Po0.0001 (***) for both comparisons), and the combined loss of Ink4a-Arf did not further increase the tumor incidence. In line with what has previously been shown for Kras-induced gliomagenesis (Holland et al., 2000; Uhrbom et al., 2002) , the incidence of PDGFB-induced transformation was significantly higher in Ntv-a wild-type mice than in Gtv-a wild-type mice (Fischer's exact test, P ¼ 0.0159 (*)). However, upon loss of either Ink4a or Arf, or combined loss of both Ink4a-Arf the difference in tumor incidence between Ntv-a and Gtv-a mice disappeared. Thus, the major effect of Ink4a-loss in PDGFB-induced oligodendroglioma formation was to increase the susceptibility of the target cells in Gtv-a mice to PDGFB-induced transformation.
The main consequence of Arf-loss was increased malignancy and shorter survival of tumor-bearing mice. This was most obvious in Gtv-a mice but the trend could also be seen in Ntv-a mice. In Gtv-a mice, there was a significant difference in survival between Ink4aÀ/À mice and ArfÀ/À mice, which was not further increased by the combined loss of Ink4a-Arf (Figure 2a ). This difference was paralleled by a significant increase in malignancy of ArfÀ/À tumors (Fischer's exact test, P ¼ 0.0001 (***)) and Ink4a-ArfÀ/À tumors (Fischer's Abbreviations: PDGFB, platelet-derived growth factor B; RCAS, replication-competent avian leukemia virus splice acceptor.
Role of Ink4a and Arf in PDGF-induced gliomagenesis E Tchougounova et al exact test, P ¼ 0.0015 (**)), when compared with Ink4aÀ/À tumors. In Ntv-a mice significant differences in survival were found between wild-type mice and Ink4aÀ/À mice or Ink4a-ArfÀ/À mice (Figure 2b ), which could be explained by increased tumor incidence and malignancy, respectively. The proportion of grade III tumors in Ntv-a mice showed a rising trend with loss of Arf and Ink4a-Arf. There was a significant difference in tumor malignancy when comparing Ntv-a wild-type mice with Ntv-a Ink4a-ArfÀ/À mice (Fischer's exact test, P ¼ 0.0292 (*)), and even more convincing so when comparing Ntv-a Ink4aÀ/À mice and Ntv-a ArfÀ/À mice (Fischers's exact test, P ¼ 0.0006 (***)) and Ntv-a Ink4aÀ/À mice and Ntv-a Ink4a-ArfÀ/À mice (Fischer's exact test, Po0.0001 (***)). Thus, loss of Arf caused tumor progression in both Ntv-a and Gtv-a mice.
To investigate the molecular mechanisms by which the separate loss of Ink4a and Arf contributed to PDGFB-induced oligodendroglioma development in vitro experiments on primary brain cells infected with either RCAS-PDGFB-HA or RCAS-X were performed. Expression of PDGFB was confirmed with Western blot for HA on cell lysates derived from the infected cells of different genetic backgrounds (Figure 3a) . Activation of the MAPK and the PI3K pathways were studied since they have been shown to be activated in human glioma. There was a clear activation of Erk in all cells upon chronic PDGFB stimulation (Figure 3b ). Activation of Immunohistochemical analysis of the expression of NG2 (e), Sox2 (f), Gfap (g) and Nestin (h). Scale bar. 50 mm.
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Akt could not be detected in any cells even after long exposures (Figure 3b ). In addition, elevated total levels of Erk and Akt expression were found in ArfÀ/À and Ink4a-ArfÀ/À cells, particularly upon PDGFB stimulation. These results suggested a central role for the MAPK pathway during PDGFB-induced tumor initiation.
To analyse possible downstream targets of the PI3K pathway, the activation of the serine/threonine kinase p70S6K was analysed. It has previously been shown that PDGFB stimulation of human glioma cells can induce activation of p70S6K (Van Brocklyn et al., 1997) . We found that chronic PDGFB stimulation in combination with Arf-loss (in ArfÀ/À and Ink4a-ArfÀ/À cells) showed a high activation of p70S6K as compared to wild-type and Ink4aÀ/À cells (Figure 3c ). Also, the total level of p70S6K was pronouncedly higher in these cells.
To investigate if the PI3K pathway and/or the MAPK pathway were involved in the activation of p70S6K, we Figure 2 Kaplan-Meier graphs of glioma-free survival in PDGFB-injected Gtv-a mice (a) and Ntv-a mice (b). Statistical analyses using the log-rank test was performed on all possible comparisons and showed significant differences in survival between Ntv-a wild-type and Ntv-a Ink4aÀ/À, P ¼ 0.0236 (*); Ntv-a wildtype and Ntv-a Ink4a-ArfÀ/À, P ¼ 0.0003 (***); Ntv-a Ink4aÀ/À and Ntv-a Ink4a-ArfÀ/À, P ¼ 0.0467 (*); Ntv-a ArfÀ/À and Ntv-a Ink4a-ArfÀ/À, P ¼ 0.0348 (*); Gtv-a wild-type and Gtv-a Ink4aÀ/À, Po0.0001 (***); Gtv-a wild-type and Gtv-a ArfÀ/À, Po0.0001 (***); Gtv-a wild-type and Gtv-a Ink4a-ArfÀ/À, Po0.0001 (***); Gtv-a Ink4aÀ/À and Gtv-a ArfÀ/À, P ¼ 0.0017 (**); Ntv-a wildtype and Gtv-a wild-type, P ¼ 0.0041 (**); Ntv-a ArfÀ/À and Gtv-a ArfÀ/À, P ¼ 0.0116 (*). 
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E Tchougounova et al treated the cells with the PI3K inhibitor LY294002 or the mitogen-induced extracellular kinase (MEK) inhibitor U0126. The PI3K inhibitor was shown to inhibit specifically the activation of p70S6K whereas the MEK inhibitor had no effect on its activation (Figure 2d) . Hence, the PDGFB-induced activation of p70S6K was conveyed via PI3K in an Akt-independent manner. Since activation of p70S6K previously has been shown to lead to an upregulation of cyclin D1 (Grewe et al., 1999) , we investigated the status of cyclin D1 in our cells. We found that the expression of cyclin D1 was induced in PDGFB-stimulated cells and that the induction was higher in ArfÀ/À and Ink4a-ArfÀ/À cells (Figure 3a) . To investigate if there was a direct functional relationship between the activation of p70S6K and the level of cyclin D1, chronically PDGFB-infected cells were treated with LY294002 or U0126 (Figure 3d ). The result showed no such direct regulation of cyclin D1 levels by p70S6K. The PDGFBinduced expression of cyclin D1 was clearly independent of the activation of the PI3K pathway. This implies that one mechanism by which loss of Arf contributes to tumor progression in our in vivo mouse model is via PDGFB-dependent expression and activation of p70S6K and expression of cyclin D1.
The observation that ArfÀ/À cells but not Ink4a-ArfÀ/À cells showed higher basal levels of cyclin D1 and p70S6K led us to investigate the expression of p16
Ink4a in these cells. We found that the level of p16
Ink4a was increased in the Arf-null cells compared to wild-type cells (Figure 3a) . This was in accordance with a previous report showing that Arf-null cells retained expression of p16
Ink4a
, which was increased during serial passage of the cells (Serrano et al., 1996; Kamijo et al., 1997a) . A plausible explanation of the increased levels of cyclin D1 and p70S6K found in our ArfÀ/À cells could be that they are the consequence of a compensatory mechanism required to override the growth inhibitory signal caused by the high expression of p16
. We also found that p16
Ink4a was induced upon PDGF stimulation, an observation in line with a previous report coupling PDGF stimulation with nuclear localization of bcatenin and increased expression of p16
Ink4a (Fischer et al., 2006) .
Primary cells from Ntv-a wild type, Ntv-a Ink4aÀ/À, Ntv-a ArfÀ/À and Ntv-a Ink4a-ArfÀ/À mice were investigated for their proliferative response to PDGFB stimulation (Figure 4a and b) . All cells showed increased proliferation in response to PDGFB stimulation but the combinations of PDGFB stimulation and loss of Arf or Ink4a-Arf resulted in the highest proliferative response. Ntv-a wild type and Ntv-a Ink4aÀ/À cells were much less responsive to PDGFB stimulation and also had significantly lower basal proliferation rate. This was in agreement with the in vivo situation where immunohistochemical staining of tumors for Ki-67 clearly showed more positive cells in Ntv-a ArfÀ/À (Figure 4c and d) and Ink4a-ArfÀ/À mice (data not shown and Figure 4d ) than in wild-type (Figure 4c and d) and Ink4aÀ/À mice (data not shown and Figure 4d ).
Discussion
There were significant and cell type-specific consequences of loss of Ink4a and Arf in PDGFB-induced oligodendroglioma formation in Ntv-a and Gtv-a mice. The main findings were that (i) in Gtv-a mice (transformation of astrocytes) loss of Ink4a had a major impact on tumor initiation and caused an increased tumor incidence similar to that of loss of Arf or Ink4a-Arf, and (ii) loss of Arf in both Ntv-a and Gtv-a mice caused increased malignancy of tumors which was not further enhanced by the combined loss of Ink4a-ArfÀ/À. The clear effect of Ink4a-loss on the tumor incidence in Gtv-a mice but not in Ntv-a mice implies a differential role for Ink4a in astrocytes versus glial progenitor cells, keeping astrocytes in a non-permissive differentiation state for PDGFB-induced transformation. The fact that all tumors induced from astrocytes were positive for the neural stem cell marker Sox2 strongly indicated that a dedifferentiation process had occurred in these tumors. The main consequence of Arf-loss was to contribute to tumor progression in both Ntv-a and Gtv-a mice and in addition shorter survival of tumor-bearing Gtv-a mice.
The in vitro experiments suggested a mechanism where the PDGFB-induced activation of the MAPK pathway leading to a slight increase in proliferation was sufficient for the initiation of low-grade oligodendrogliomas. The additional loss of Arf contributed to tumor progression due to increased levels of cyclin D1 and a PI3K-dependent but apparently Akt-independent activation of p70S6K causing a strong proliferative response of the cells.
The intriguing finding that the basal levels of both p70S6K and cyclin D1 were considerably higher in the ArfÀ/À cells compared to wild-type, Ink4aÀ/À and Ink4a-ArfÀ/À cells directed us investigate the status of p16
Ink4a
. The rationale was that in normal mouse cells the levels of p16
Ink4a and p19 Arf are increased during serial passage eventually leading to replicative senescence (Zindy et al., 1997) . Cells deficient for Arf or Ink4a-Arf may escape senescence (Serrano et al., 1996; Kamijo et al., 1997a) albeit maintaining a high expression of p16
Ink4a in the Arf-null cells. We reasoned that the increased levels of cyclin D1 and p70S6K found in our ArfÀ/À cells could be the consequence of a compensatory mechanism required to counteract the effect of the p16 Ink4a expression. However, the influence of modifier genes cannot be entirely excluded. The ArfÀ/À line was made in WW6 ES cells which are 75% 129/Sv, 20% C57Bl6 and 5%SJL (Ioffe et al., 1995) and the Ink4a-ArfÀ/À line was made in RW4 ES cells which are 100% 129/Sv (Schumacher et al., 2003) . Yet, we find it unlikely that the minor difference in genetic background would be the sole cause of such a prominent cellular effect.
For the development of successful targeted therapeutic treatment of human glioma, it is essential to know how different combinations of mutations collaborate to activate downstream oncogenic signaling pathways. High-grade astrocytomas, both from patients and from several different mouse models, have displayed activation of the PI3K pathway via Akt as a seemingly obligatory event (Holland et al., 2000; Bachoo et al., 2002; Charest et al., 2006) . Here, we have shown that also for the development of high-grade oligodendrogliomas the PI3K pathway is activated, although in an apparently Akt-independent manner. Future efforts will be focused on further dissecting the signaling events in oligodendroglioma development in order to try to identify unique targets for this tumor type.
Materials and methods

Generation of mice, in vivo virus infection and tumor surveillance
The ArfÀ/À mice (Kamijo et al., 1997b) , the Ink4aÀ/À mice (Sharpless et al., 2001 ) and the Ink4a-ArfÀ/À mice (Serrano et al., 1996) were crossed with the Ntv-a and Gtv-a transgenic mouse lines. Heterozygous mice were subsequently intercrossed and all injections were made in the F4 or later generation of mice. The Ink4aÀ/À line was made in WW6 ES cells, injected into C57Bl6 blastocysts and chimeras were mated with C57Bl6 mice. The ArfÀ/À line was made in WW6 ES cells, injected into C57Bl6 blastocysts and chimeras were mated with C57Bl6 mice. The Ink4a-ArfÀ/À line was made in RW4 ES cells, injected into C57Bl6 blastocysts and chimeras were mated with C57Bl6 mice.
Neonatal mice were injected in the right cerebral hemisphere with DF-1 chicken fibroblasts producing RCAS-PDGF-EGFP and monitored as described (Uhrbom et al., 2002) . Experiments were performed in accordance with the local animal ethics committee. 
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Primary tissue culture and proliferation assay Primary brain cell cultures were prepared from neonatal Ntv-a wild-type, Ntv-a Ink4aÀ/À, Ntv-a ArfÀ/À and Ntv-a Ink4a-Arf À/À mice as described (Uhrbom et al., 2005) . Cells were expanded for two passages and stored as frozen aliquots. To infect the primary Ntv-a cells, supernatants from DF-1 chicken fibroblast cells producing either RCAS-PDGFB-HA or RCAS-X (control virus) were used. Conditioned media from the respective retroviral producing cells was collected after 24 h, sterile-filtered through 0.45 mm filters and added to the primary Ntv-a cell cultures. The infection was repeated every day for 1 week. For the proliferation assay, 2 Â 10 4 infected cells per 35-mm dish were plated, duplicate samples for each time point. The cell number per dish was determined at days 1, 4 and 7 using a Coulter counter (Coulter Electronics, Bromma, Sweden). The proliferation assay was repeated three times.
Histopathology and statistical analyses of tumor numbers
Mouse brains were fixed in formalin, cut into five pieces, embedded in paraffin, sectioned and analysed for presence or absence of tumor tissue by viewing hematoxylin and eosin (H&E)-stained sections. Statistical analyses were performed in the GraphPad Software Prism 4.0a using the log-rank test applied to Kaplan-Meier graphs, and the Fischer's exact test for the comparison of incidence rates and malignancy grades.
Immunohistochemical analyses and quantification of Ki-67-positive cells Immunostainings were performed as described previously (Uhrbom et al., 2005) . Antibodies used were monoclonal anti-GFAP (Chemicon, Hampshire, UK), monoclonal antinestin (Pharmingen, BD Biosciences, Stockholm, Sweden), rabbit polyclonal anti-NG2 chondroitin sulfate proteoglycan (Chemicon, Temecula, CA, USA), rat monoclonal anti-Ki-67 (DakoCytomation, Glostrup, Denmark) and rabbit polyclonal anti-Sox2 (Chemicon).
The quantification of Ki-67-positive tumor cells was determined from two representative tumors each from Ntv-a wildtype, Ntv-a Ink4aÀ/À, Ntv-a ArfÀ/À and Ntv-a Ink4a-ArfÀ/À mice. The percentage of Ki-67-positive nuclei out of 500 randomly selected cells was calculated.
Protein extraction and Western blot analyses
Infected cells were washed twice with and incubated in serumfree Dulbecco's modified Eagle's medium for 19 h. The small molecule inhibitors LY 294002 (10 mM in dimethyl sulfoxide (DMSO); Promega, Madison, WI, USA) and U0126 (10 mM in DMSO; Promega) or only DMSO were added 4 h before collection of cells. Protein extracts and Western blots were performed as described previously (Uhrbom et al., 2005) . Membranes were immunoblotted at 41C overnight with the primary antibodies p44/42 MAPK, phospho-p44/42 MAPK (Cell Signaling, Beverly, MA, USA), phospho-Akt (Thr308) (Cell Signaling), Akt (Cell Signaling), cyclin D1 (H-295; Santa Cruz Biotechnology, Santa Cruz, CA, USA), HA-probe (Y-11) (Santa Cruz), p16
Ink4a (M-156; Santa Cruz), phospho-p70S6 kinase (Thr 421/Ser 424)-R (Santa Cruz), p70S6 kinase (C-18; Santa Cruz), actin (Chemicon, Temecula, CA, USA). Horseradish peroxidase-coupled secondary antibodies (Amersham Biosciences, Little Chalfont, Buckinghamshire, UK) were used and the reaction was visualized with SuperSignal West Pico Chemiluminescent Substrate (Pierce, Cramlington, Northumberland, UK) on Hyperfilm-ECL (Amersham, Amersham Biosciences).
